Journal
CELL METABOLISM
Volume 4, Issue 4, Pages 303-311Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2006.09.003
Keywords
-
Categories
Funding
- Wellcome Trust [080237] Funding Source: Medline
Ask authors/readers for more resources
PPAR gamma is essential for adipogenesis and metabolic homeostasis. We describe mutations in the DNA and ligand binding domains of human PPAR gamma in lipodystrophic, severe insulin resistance. These receptor mutants lack DNA binding and transcriptional activity but can translocate to the nucleus, interact with PPAR gamma coactivators and inhibit coexpressed wild-type receptor. Expression of PPAR gamma target genes is markedly attenuated in mutation-containing versus receptor haploinsufficent primary cells, indicating that such dominant-negative inhibition operates in vivo. Our observations suggest that these mutants restrict wild-type PPAR gamma action via a non-DNA binding, transcriptional interference mechanism, which may involve sequestration of functionally limiting coactivators.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available